Generate a tailored SOP for Dr. Renumathy Dhanasekaran. Improve your application with a focused, well-structured draft.
Renumathy Dhanasekaran integrates clinical care, molecular biology, and translational research to improve the understanding and treatment of liver cancer. After completing a Gastroenterology fellowship at Mayo Clinic and a Transplant Hepatology fellowship, she obtained her PhD in Cancer Biology from Stanford University. Dhanasekaran leads an independent research program focused on the immunobiology of hepatocellular carcinoma (HCC). Her laboratory employs spatial single-cell technologies and patient-derived tissues to identify biomarkers of disease progression and therapeutic response, aiming to develop targeted treatment strategies. She has received multiple awards for her impactful work, including the NCI R37 MERIT Award and is a recipient of prestigious grants from organizations such as the NIH and the American Gastroenterological Association. Clinically, she specializes in managing patients with liver tumors and aims to introduce innovative diagnostics and therapeutic strategies into clinical practice. Dhanasekaran is committed to personalized care for patients suffering from liver cancer, emphasizing a compassionate and multidisciplinary approach to treatment.
Stanford University • Stanford, CA
Leads an independent research program aimed at understanding liver cancer and advancing clinical practices in hepatology.
The Computer Science department emphasizes research potential. GRE General is currently optional but recommended for some tracks.